(Q38427892)

3 September 2017

title

The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and HER2/neu status in breast carcinoma (English)

1 reference

3 September 2017

main subject

neoadjuvant chemotherapy

1 reference

Amy L Adams

1

1 reference

3 September 2017

Isam Eltoum

2

1 reference

3 September 2017

Helen Krontiras

3

1 reference

3 September 2017

Wenquan Wang

4

1 reference

3 September 2017

David C Chhieng

5

1 reference

3 September 2017

publication date

31 January 2008

1 reference

3 September 2017

1 reference

3 September 2017

volume

14

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

141-146

1 reference

Preoperative (neoadjuvant) systemic treatment of breast cancer

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

Mode of action of docetaxel - a basis for combination with novel anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

Stability of the HER2 gene after primary chemotherapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00544.X

10.1111/J.1524-4741.2007.00544.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference